| Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550) |
|---|
| 02/03/2005 | US20050026875 Treating bacterial, viral, or fungal infections, cancer, a lung injury, an eye disorder, neurological disorder or stroke |
| 02/03/2005 | DE10330358A1 New arylalkanol derivatives used for treating e.g. respiratory diseases, joint diseases, vascular inflammations, skin disorders, kidney and liver diseases and neurological diseases |
| 02/03/2005 | DE10130504B4 Xanthin- und Phenazon-Acesulfam-H-Komplexe mit verbessertem Geschmack, Verfahren zu ihrer Herstellung und ihre Verwendung Xanthine-phenazone and acesulfame-H-complexes with improved taste, process for their preparation and their use |
| 02/03/2005 | CA2744317A1 Substituted tetracycline compounds |
| 02/03/2005 | CA2533494A1 Aryl heteroaromatic products, compositions comprising the same and use thereof |
| 02/03/2005 | CA2533392A1 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use |
| 02/03/2005 | CA2532403A1 Ppar active compounds |
| 02/03/2005 | CA2532231A1 Aminopyrazole compounds and use as chk1 inhibitors |
| 02/03/2005 | CA2529036A1 Indane derivates as muscarinic receptor agonists |
| 02/02/2005 | EP1501841A2 Non nucleoside reverse transcriptase inhibitors |
| 02/02/2005 | EP1501810A1 Ionic liquids |
| 02/02/2005 | EP1501805A1 Substituted pyrazolyl compounds for the treatment of inflammation |
| 02/02/2005 | EP1299389A4 A process for preparing pyrazolopyrimidinone derivatives for the treatment of impotence |
| 02/02/2005 | CN1575279A Substituted thioacetamides |
| 02/02/2005 | CN1575273A 3, 4-di-substituted cyclobutene-1, 2-diones as CXC-chemokine receptor antagonists |
| 02/02/2005 | CN1572792A Pyrazolo [4, 3-d] pyrimidine derivatives |
| 02/02/2005 | CN1187335C Benzoylpyrazols and their use as herbicides |
| 02/01/2005 | US6849745 Fluorescent dye for use in the detection of preferential compounds |
| 02/01/2005 | US6849653 Substituted pyrazolyl benzenesulfamide compounds for the treatment of inflammation |
| 02/01/2005 | US6849649 N-phenpropylcyclopentyl-substituted glutaramide derivatives as inhibitors of neutral endopeptidase |
| 02/01/2005 | US6849631 Semicarbazides and their uses |
| 02/01/2005 | US6849623 For use as human and veterinary medicine |
| 02/01/2005 | US6849618 Herbicidal compositions for the desiccation/ defoliation of plants |
| 02/01/2005 | US6849617 Administering Tissue factor pathway inhibitors for prophylaxis of thrombosis and cardiovascular disorders; anticoagulants |
| 01/27/2005 | WO2005007635A2 Combretastatin derivatives with cytotoxic action |
| 01/27/2005 | WO2005007621A2 Ubiquitin ligase inhibitors |
| 01/27/2005 | WO2005007620A2 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
| 01/27/2005 | WO2004098518A3 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/27/2005 | WO2004096757A8 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 01/27/2005 | US20050020659 Substituted pyrazole derivatives and related compounds as bradykinin B1 receptor antagonists |
| 01/27/2005 | US20050020602 Bone disorders; reduction concentration of parathyroid hormone in blood |
| 01/27/2005 | US20050020593 Anticancer agents |
| 01/27/2005 | US20050020584 Benzamide derivatives as antagonists of orexin receptors |
| 01/27/2005 | US20050020564 Pyrazole-amides and sulfonamides as sodium channel modulators |
| 01/27/2005 | US20050015893 Hair dyes, oxidation color dyes for human hair |
| 01/27/2005 | DE10331496A1 Verfahren zum Herstellen von Difluoracetessigsäurealkylestern A process for producing Difluoracetessigsäurealkylestern |
| 01/27/2005 | CA2531389A1 Combretastatin derivatives with cytotoxic action |
| 01/27/2005 | CA2530175A1 New n-hydroxy-4-(3-phenyl-5-methyl-isoxazole-4-yl)-benzenesulfonamide solvates |
| 01/26/2005 | EP1499600A1 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 01/26/2005 | EP1499597A2 Compounds and methods for inducing apoptosis in proliferating cells |
| 01/26/2005 | CN1186342C Substituted (4-bromopyrazole-3-yl) indole |
| 01/26/2005 | CN1186332C New thryoid receptor ligands and process II |
| 01/25/2005 | US6846935 Reacting 1,1,1-trifluoro-4-(2,4-difluorophenyl)-3-buten-2-one with phenylhydrazine chlorhydrate, to form 1-phenyl-5-(2,4-difluorophenyl)-4,5-dihydro-3-trifluoromethyl-1H-pyrazole, then resolving into stereoisomers; enzyme inhibitors |
| 01/25/2005 | US6846919 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 01/25/2005 | US6846825 Antibacterial agents |
| 01/25/2005 | CA2191647C Process improvement in the synthesis of n-[3-(3-cyanopyrazolo[1,5-a]pyrimidin-7-yl)phenyl]-n-ethylacetamide |
| 01/25/2005 | CA2068224C Novel potent inducers of terminal differentiation and method of use thereof |
| 01/20/2005 | WO2005005393A2 Cck-1 receptor modulators |
| 01/20/2005 | WO2005004810A2 Arylsulfonamide derivatives |
| 01/20/2005 | WO2004069158A3 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 01/20/2005 | US20050014813 High yield; synthetic pharmaceutical intermediate; diabetes, insulin sensitizers |
| 01/20/2005 | US20050014805 Hypotensive agents; antidiabetic agents; cardiovascular disorders; anticholesterol agents; anticancer agents |
| 01/20/2005 | US20050014787 5-amidino-2-hydroxybenzenesulfonamide derivatives medicinal compoistions containing the same medicinal use thereof and intermediates in the production thereof |
| 01/20/2005 | US20050014649 Herbicides; and synthesis thereof |
| 01/20/2005 | CA2530737A1 Cck-1 receptor modulators |
| 01/19/2005 | EP1496900A2 New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors |
| 01/19/2005 | EP1496892A2 1h-benzo(f)indazol-5-yl derivatives as selective glucocorticoid receptor modulators |
| 01/19/2005 | EP1496838A2 Substituted amides |
| 01/19/2005 | EP1230244B1 Pyrazolecarboxylic acid tricyclic derivatives, preparation and pharmaceutical compositions containing same |
| 01/19/2005 | CN1568185A Compounds effecting glucokinase |
| 01/19/2005 | CN1566096A Prostaglandin agonists and their use to treat bonedisorders |
| 01/19/2005 | CN1185234C Herbicidally active 3-hydroxy-4-aryl-5-oxopyrazoline derivatives |
| 01/18/2005 | US6844436 Chlorosulfonation, cyclization, salt formation'; impotency; cardiovascular disorders; antidiabetic agents; central nervous system disorders |
| 01/18/2005 | US6844407 Nitrogen-nitrogen bond covalently bonded to a thiocarbonyl moiety |
| 01/16/2005 | WO2005000281A2 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 01/16/2005 | CA2529436A1 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 01/13/2005 | WO2005003098A1 Heterocyclically substituted pentanol derivatives, method for the production thereof, and use thereof as anti-inflammatory agents |
| 01/13/2005 | WO2005003077A1 Method for producing difluoro-acetyl-acetic acid alkylesters |
| 01/13/2005 | WO2005002574A1 Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors |
| 01/13/2005 | WO2004099134A3 Glutaminyl based dp iv-inhibitors |
| 01/13/2005 | US20050009900 3-Substituted with a heterocyclic group, e.g., 2-Chloro-5-[1-(2,3-dihydroxy-propyl)-5-methyl-1H-pyrazol-3-yl]-N-(1-hydroxy-cycloheptylmethyl)-benzamide; treatment of IL-1 mediated disorders, including osteo- and rheumatoid arthritis, allergies, asthma, COPD, cancer, and reperfusion or ischemia in stroke |
| 01/13/2005 | US20050009896 Drugs comprising combination of antithrombotic agent with pyrazolone derivative |
| 01/13/2005 | US20050009876 Indazole compounds, compositions thereof and methods of treatment therewith |
| 01/13/2005 | US20050009871 Ubiquitin ligase inhibitors |
| 01/13/2005 | US20050009834 E.g., 3-(2-chloro-6-fluorophenyl)-1-[4-(3,5-dichloropyridin-2-yloxymethyl)phenyl]-5-methyl-1H-1,2,4-triazole and 3-(3-chloropyridin-2-yl)-1-[4-(3-chloro-5-trifluoromethylpyridin-2-yloxymethyl)phenyl]-5-methyl-1H-1,2,4-triazole; for use as pesticides, especially insecticides and acaricides |
| 01/13/2005 | US20050009819 1-Aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands |
| 01/13/2005 | CA2531060A1 Heterocyclically-substitued pentanol derivatives, process for their production and their use as anti-inflammatory agents |
| 01/12/2005 | EP1495035A1 Method for the production of bis(perfluoroalkyl)phosphinic acids and the salts thereof |
| 01/12/2005 | EP1495015A1 3-aminophenol derivatives and dyes that contain these compounds while serving to dye keratin fibers |
| 01/12/2005 | EP1495005A1 Pyrazole compounds as anti-inflammatory and analgesic agents |
| 01/12/2005 | EP1494997A1 Substituted aryl amides |
| 01/12/2005 | EP1494993A2 Novel curcumin analogues and uses thereof |
| 01/12/2005 | EP1494989A2 Compounds that modulate ppar activity and methods for their preparation |
| 01/12/2005 | EP1494673A1 Compounds having unique cb1 receptor binding selectivity and methods for their production and use |
| 01/12/2005 | EP1494666A1 Orally deliverable pharmaceutical composition comprising an active compound having an aminosulfonyl group (cox-2 inhibitor), a polyethylene glycol and a free-radical scavenging antioxidant |
| 01/12/2005 | EP1494645A2 Method of treating mucus hypersecretion |
| 01/12/2005 | EP0944604B1 Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 01/12/2005 | CN1562976A Method for synthesizing 1-methyl-benzdiazole-3-formic acid |
| 01/12/2005 | CN1184207C Process for producing insecticide intermediate |
| 01/12/2005 | CN1184206C Prepn process of pyrazole derivative |
| 01/11/2005 | US6841624 Subjecting mixture of one or more monomers, at least one free radical source and a control agent to polymerization condition, wherein control agent contains at least one N-N bond covalently bonded to a thiocarbonyl group |
| 01/11/2005 | CA2284051C Pharmaceutical composition for oral administration of a n-piperidino-3-pyrazolecarboxamide derivative, its salts and their solvates |
| 01/06/2005 | WO2005002293A2 Cox-2-targeted imaging agents |
| 01/06/2005 | WO2005000820A2 4-cyanopyrazole-3-carboxamide derivatives preparation and application thereof as cb1 cannabinoid antagonists |
| 01/06/2005 | WO2005000813A1 Heteroarylamino-phenylketone derivatives and their use as kinase inhibitors |
| 01/06/2005 | WO2005000800A1 Cathepsin cysteine protease inhibitors |
| 01/06/2005 | WO2005000309A2 Chemical compounds |
| 01/06/2005 | US20050004176 Pyrazole-amide compounds useful as kinase inhibitors |
| 01/06/2005 | US20050004135 Pyrazole ether derivatives as anti-inflammatory/analgesic agents |
| 01/06/2005 | US20050004133 Inhibiting ligand gated ion channel vanilloid receptor (VR1); pain relievers; such as 6-(3,4-dichloro-phenyl)-N-(2-oxo-2,3-dihydro-1H-benzoimidazol-5-yl)-nicotinamide |